Safety and pharmacokinetics of gb1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants
HIGHLIGHTS who: Vassilios Aslanis from the Galecto Biotech AB, Copenhagen N, Denmark have published the article: Safety and pharmacokinetics of […]